# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Frida Kahlo (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI011-SYN
- Date: 2026-09-17
- Fictional facility: St. Posthumous Health Center
- Fictional author: Marisol Ortega, MD
- Calendar frame: modern shifted

## Subjective

The patient participates in this fictional visit for new primary care visit for chronic back, pelvic, and right leg pain on long-term opioid therapy. **S**

## Objective

ALT: 22 U/L; Creatinine: 0.72 mg/dL; eGFR: 110 mL/min/1.73 m²; 25-hydroxyvitamin D: 18 ng/mL (low); PEG pain and function score (0-10): 7.3; PHQ-9: 8. All results are synthetic.

BP 118/74 mmHg; pulse 82 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 50 kg; BMI 19.5 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Chronic low back and pelvic pain after remote spinal and pelvic fractures and spinal surgery, with neuropathic features in the right leg; linked to the documented 1925 injuries; Post-traumatic osteoarthritis of the right ankle and foot after multiple leg fractures and a foot dislocation; Right leg weakness, atrophy, and shortening after childhood poliomyelitis; a congenital spinal anomaly has been proposed retrospectively; Long-term opioid therapy for chronic pain, 60 MME a day at intake; Vitamin D deficiency. Strengths and supports remain part of the care plan. **S**

## Medication changes

- Continued without change: Oxycodone 10 mg oral tablet, one tablet every 6 hours as needed for pain, no more than four a day (60 MME a day) **S**
- Started: Duloxetine 30 mg delayed-release oral capsule, one capsule daily **S**
- Started: Acetaminophen 500 mg oral tablet, two tablets three times daily **S**
- Started: Diclofenac sodium 1% topical gel, 2 g to the right ankle four times daily **S**
- Started: Cholecalciferol (vitamin D3) 2,000 units oral tablet, one tablet daily **S**
- Started: Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose; may repeat in the other nostril **S**

## Plan

- Physical medicine and rehabilitation referral for a multimodal rehabilitation plan: exercise therapy, bracing and orthotic review, a shoe lift for the leg-length difference, and function goals. Guideline: Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians (2017); VA/DoD Clinical Practice Guideline for the Diagnosis and Treatment of Low Back Pain (2022) **S**
- Nonopioid treatment first: duloxetine titrated to 60 mg daily, scheduled acetaminophen up to 3 g a day, and topical diclofenac for the ankle. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022); Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians (2017); CMID: Clinical Monitoring Intelligence Database, osteoarthritis and depression monographs (2026) **S**
- Opioid risk mitigation: review benefits and harms together, check the prescription drug monitoring program, urine drug test with consent, prescribe naloxone 4 mg nasal spray and teach a family member, and avoid benzodiazepines and other sedatives. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022) **S**
- Collaborative, gradual opioid taper of about 10% of the dose a month, paused if pain or function worsens; never stop opioids abruptly. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022) **S**
- Measure pain and function with the PEG at every visit and depressive symptoms with the PHQ-9 every two to four weeks; complete a structured safety assessment if the PHQ-9 reaches 10 or item 9 is positive. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022); CMID: Clinical Monitoring Intelligence Database, osteoarthritis and depression monographs (2026) **S**
- Check ALT periodically on regular acetaminophen, and replete vitamin D. Guideline: CMID: Clinical Monitoring Intelligence Database, osteoarthritis and depression monographs (2026) **S**
